about
Towards Therapeutic Delivery of Extracellular Vesicles: Strategies for In Vivo Tracking and Biodistribution AnalysisThe beneficial effect of Zinc(II) on low-dose chemotherapeutic sensitivity involves p53 activation in wild-type p53-carrying colorectal cancer cellsPromotion of Survival and Engraftment of Transplanted Adipose Tissue-Derived Stromal and Vascular Cells by Overexpression of Manganese Superoxide Dismutase.Targeting MKK3 as a novel anticancer strategy: molecular mechanisms and therapeutical implications.Hyperglycemia triggers HIPK2 protein degradation.Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist.p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditionsChallenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies.Stem cells under the influence of alcohol: effects of ethanol consumption on stem/progenitor cellsProtein disulfide isomerase as a prosurvival factor in cell therapy for muscular and vascular diseasesOverexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer developmentEffects of Copper Chelation on BRAFV600E Positive Colon Carcinoma Cells.Current Biomedical Use of Copper Chelation TherapyIntraoperative Strategies for Minimal Manipulation of Autologous Adipose Tissue for Cell- and Tissue-Based Therapies: Concise ReviewExtracellular Vesicles-Encapsulated MicroRNA-125b Produced in Genetically Modified Mesenchymal Stromal Cells Inhibits Hepatocellular Carcinoma Cell ProliferationDHA Affects Microtubule Dynamics Through Reduction of Phospho-TCTP Levels and Enhances the Antiproliferative Effect of T-DM1 in Trastuzumab-Resistant HER2-Positive Breast Cancer Cell Lines
P50
Q28075450-96C42485-C21E-4973-A399-4118A5950EFCQ35986990-1E5DCFC2-18C6-4A0C-8E3F-EAB1660192DAQ36072645-4EB72A63-C1A1-4C68-A469-C0EEA0DD471CQ36347205-E8DA55FA-3A7C-4D7B-9A0B-AC9C61FC0DDEQ37702069-A665DB06-39AB-40E4-B8EA-BAA898ABA527Q38977664-B804807B-155D-4C45-8680-92EFEF53608FQ41279239-7E7ED963-3DEF-4BF1-89BA-FD01F119D3B9Q44298061-091A9AA9-A481-4EC2-B44B-D321A051C5A5Q57283118-6F2B96FB-DAE4-41FC-AAF9-772712DFC84FQ58694834-EB8654F7-D04A-4191-968B-6E82E0229B0CQ64079819-63074B6C-C22E-4905-AC63-9CD86573EDC2Q64949252-4D054111-8383-45C0-9FDF-84F1634F4250Q89633274-2DA06ADF-6626-489A-849A-5DBD362B8021Q90625419-9362A1F1-4119-4397-9D07-3D247422D467Q91807824-11DCF14B-B462-40D1-9642-7C2802FE9B56Q95304752-042579FB-A2B1-4959-96D4-20C9B59EFD6B
P50
description
investigador
@es
researcher
@en
name
S Baldari
@en
type
label
S Baldari
@en
prefLabel
S Baldari
@en
P31
P496
0000-0001-7982-9468